Abstract
The Surviving Sepsis Campaign (SSC), an initiative of the European Society of Intensive Care Medicine (ESICM), the International Sepsis Forum (ISF), and the Society of Critical Care Medicine (SCCM), was developed in 2002 in a global effort to improve the management, diagnosis, and treatment of sepsis. The three planned phases of the SSC reached a conclusion in December 2008, but the ideas created continue to impact on the daily management of the patient with severe sepsis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Dellinger RP, Carlet JM, Masur H, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555
Dellinger RP, Carlet JM, Masur H, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873
Dellinger RP, Levy MM, Carlet JM, et al. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60
Dellinger RP, Levy MM, Carlet JM, et al. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327
Vincent JL, Marshall JC (2008) Surviving sepsis: A guide to the guidelines. Crit Care 12:162
Guyatt G, Gutterman D, Baumann MH, et al. (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians Task Force. Chest 129:174–181
Gao F, Melody T, Daniels DF, et al. (2005) The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: A prospective observational study. Crit Care 9:R764–R770
Micek ST, Roubinian N, Heuring T, et al. (2006) Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 34:2707–2713
Shorr AF, Micek ST, Jackson WL, Jr, Kollef MH (2007) Economic implications of an evidencebased sepsis protocol: Can we improve outcomes and lower costs? Crit Care Med 35:1257–1262
Nguyen HB, Corbett SW, Steele R, et al. (2007) Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 35:1105–1112
Baldwin LN, Smith SA, Fender V, et al. (2008) An audit of compliance with the sepsis resuscitation care bundle in patients admitted to A&E with severe sepsis or septic shock. Int Emerg Nurs 16:250–256
Ferrer R, Artigas A, Levy MM, et al. (2008) Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299:2294–2303
Zambon M, Ceola M, Almeida-de-Castro R, et al. (2008) Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: We could go faster. J Crit Care 23:455–460
Vincent JL, Sakr Y, Sprung CL, et al. (2006) Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34:344–353
Angus DC, Linde-Zwirble WT, Lidicker J, et al. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
Davies A, Green C, Hutton J, Chinn C (2001) Severe sepsis: A European estimate of the burden of disease in ICU. Intensive Care Med 27(Suppl 2):S284 (abst)
Annane D, Sebille V, Charpentier C, et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871
Sprung CL, Annane D, Keh D, et al. (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124
Van den Berghe G, Wouters P, Weekers F, et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Brunkhorst FM, Engel C, Bloos F, et al. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
Finfer S, Chittock DR, Su ST, et al. (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
Rivers E, Nguyen B, Havstad S, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377
Kumar A, Roberts D, Wood KE, et al. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
Vincent JL, O’Brian J, Wheeler A, et al. (2006) Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis. Crit Care 10:R74
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Vincent, J.L. (2009). Surviving Sepsis Campaign and Bundles. In: Gullo, A., Lumb, P.D., Besso, J., Williams, G.F. (eds) Intensive and Critical Care Medicine. Springer, Milano. https://doi.org/10.1007/978-88-470-1436-7_27
Download citation
DOI: https://doi.org/10.1007/978-88-470-1436-7_27
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1435-0
Online ISBN: 978-88-470-1436-7
eBook Packages: MedicineMedicine (R0)